Advertisement
UK markets close in 4 hours 14 minutes
  • FTSE 100

    8,085.01
    +40.20 (+0.50%)
     
  • FTSE 250

    19,800.94
    +1.22 (+0.01%)
     
  • AIM

    754.78
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1638
    +0.0010 (+0.08%)
     
  • GBP/USD

    1.2441
    -0.0012 (-0.09%)
     
  • Bitcoin GBP

    53,385.52
    +155.79 (+0.29%)
     
  • CMC Crypto 200

    1,434.50
    +10.40 (+0.73%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.77
    -0.59 (-0.71%)
     
  • GOLD FUTURES

    2,328.40
    -13.70 (-0.58%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,193.08
    +55.43 (+0.31%)
     
  • CAC 40

    8,134.16
    +28.38 (+0.35%)
     

New Strong Buy Stocks for January 13th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Arcosa, Inc. (ACA): This company that manufactures and sells infrastructure-related products and services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Arcosa, Inc. Price and Consensus

 

Arcosa, Inc. Price and Consensus
Arcosa, Inc. Price and Consensus

Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote

The Meet Group, Inc. (MEET): This company that operates a portfolio of mobile social entertainment applications to meet the need for human connection has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 90 days.

ADVERTISEMENT

Meet Group, Inc.(The) Price and Consensus

 

Meet Group, Inc.(The) Price and Consensus
Meet Group, Inc.(The) Price and Consensus

Meet Group, Inc.(The) price-consensus-chart | Meet Group, Inc.(The) Quote

SYNNEX Corporation (SNX): This company that provides business process services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.

SYNNEX Corporation Price and Consensus

 

SYNNEX Corporation Price and Consensus
SYNNEX Corporation Price and Consensus

SYNNEX Corporation price-consensus-chart | SYNNEX Corporation Quote

Tronox Holdings plc (TROX): This company that engages in the mining, production, and marketing of inorganic minerals and chemicals has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 90 days.

Tronox Limited Price and Consensus

 

Tronox Limited Price and Consensus
Tronox Limited Price and Consensus

Tronox Limited price-consensus-chart | Tronox Limited Quote

Alexion Pharmaceuticals, Inc. (ALXN): This company that develops and commercializes various therapeutic products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.

Alexion Pharmaceuticals, Inc. Price and Consensus

 

Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Tronox Limited (TROX) : Free Stock Analysis Report
 
SYNNEX Corporation (SNX) : Free Stock Analysis Report
 
Meet Group, Inc.(The) (MEET) : Free Stock Analysis Report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
Arcosa, Inc. (ACA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research